- Associated Press•15 hours ago
WASHINGTON (AP) — GlaxoSmithKline PLC has agreed to pay $20 million to resolve U.S. regulators' allegations that the pharmaceutical giant's China operations bribed officials to boost drug sales.
- The Wall Street Journal•16 hours ago
GlaxoSmithKline PLC agreed to pay $20 million to settle charges that the drugmaker’s Chinese subsidiaries engaged in bribery schemes to increase sales in the Asian country, the Securities and Exchange ...
- Reuters•18 hours ago
GlaxoSmithKline Plc will pay $20 million to settle civil charges that it masked bribes to foreign officials in China by disguising them as legitimate travel, entertainment and marketing expenses, U.S. regulators said on Friday. The pharmaceutical company agreed to settle the case with the Securities and Exchange Commission without admitting or denying any wrongdoing. In a statement, the company said it had cooperated with the SEC and it had received credit for taking steps to improve its operations, such as changing how sales representatives are paid and stopping the practice of paying healthcare professionals to speak to doctors about the company's products.
GlaxoSmithKline plc (GSK.L)
LSE - LSE Delayed Price. Currency in GBp
|Bid||1,628.50 x 175400|
|Ask||1,650.00 x 417900|
|Day's Range||1,625.85 - 1,645.00|
|52wk Range||1,277.25 - 1,716.50|
|1y Target Est||N/A|
|P/E Ratio (ttm)||2,738.33|
|Avg Vol (3m)||7,757,982|
|Dividend & Yield||N/A (N/A)|